Cipla, Sanofi India shares gain on distribution agreement
Cipla will be responsible for the distribution of Sanofi India’s six central nervous system products, including Frisium, a leading brand in the anti-epileptic medication category
Read MoreCipla will be responsible for the distribution of Sanofi India’s six central nervous system products, including Frisium, a leading brand in the anti-epileptic medication category
Read MoreShyam Metalics Energy | The LoI is valid for a period of one year from the date of issuance.
Read MoreGoldman Sachs believes RIL#39;s consolidated returns are at an inflection point in FY24, and its Cash Return on Cash Invested (CROCI) will expand by nearly 270 basis points to 12 percent in FY27, which will be the highest since 2011.
Read MoreThe meeting began at 11 a.m. (0300 GMT) following the taking of a group photo, the report said. An accompanying video showed the attendees would be sat in a square formation, with the two fully visible sides both set out…
Read MoreReports have said that Standard Chartered#39;s corporate banking section was looking to unload its entire 7.18 percent stake in CDSL for at least $151 million.
Read MoreAccording to Geojit, Farmers in Gujarat have sown crops across 868,132 ha as of today for the 2023-24 summer season, down 3.5% from 900,034 ha in the corresponding period a year ago, according to data from the state agriculture department.
Read More